TY - JOUR
T1 - High long-chain n-3 fatty acid intake attenuates the effect of high resting heart rate on cardiovascular mortality risk
T2 - A 24-year follow-up of Japanese general population
AU - The NIPPON DATA 80 Research Group
AU - Hisamatsu, Takashi
AU - Miura, Katsuyuki
AU - Ohkubo, Takayoshi
AU - Yamamoto, Takashi
AU - Fujiyoshi, Akira
AU - Miyagawa, Naoko
AU - Kadota, Aya
AU - Takashima, Naoyuki
AU - Okuda, Nagako
AU - Yoshita, Katsushi
AU - Kita, Yoshikuni
AU - Murakami, Yoshitaka
AU - Nakamura, Yasuyuki
AU - Okamura, Tomonori
AU - Horie, Minoru
AU - Okayama, Akira
AU - Ueshima, Hirotsugu
N1 - Funding Information:
This work was supported by a grant-in-aid from the Ministry of Health and Welfare under the auspices of the Japanese Association for Cerebro-cardiovascular Disease Control , by a Research Grant for Cardiovascular Diseases (7A-2) from the Ministry of Health, Labour and Welfare ; and by Health and Labour Science Research Grants (Comprehensive Research on Aging and Health Grants H11-Chouju-046 , H14-Chouju-003 , H17-Chouju-012 , and H19-Chouju-Ippan-014 , and Comprehensive Research on Life-Style Related Diseases, including Cardiovascular Diseases and Diabetes Mellitus Grant H22-Jyunkankitou-Seisyu-Sitei-017 ), Tokyo, Japan.
Publisher Copyright:
© 2014 Japanese College of Cardiology.
PY - 2014
Y1 - 2014
N2 - Background: Increased resting heart rate (RHR) independently predicts cardiovascular mortality. Meanwhile, long-chain n-3 fatty acids (LCn3FAs) have a cardioprotective effect. Our aim was to evaluate whether higher LCn3FAs intake attenuates the elevated risk of cardiovascular mortality associated with increased RHR. Methods: We conducted a population-based 24-year prospective cohort study of Japanese, whose LCn3FAs intake is relatively high. Study participants included 8807 individuals aged 30-95 years from randomly selected areas across Japan without cardiovascular diseases and anti-hypertensive drugs at baseline. The primary endpoint was cardiovascular mortality, and the secondary endpoints were cardiac and stroke mortality during 24 years of follow-up. Individual dietary LCn3FAs intake was estimated from household-based 3-day weighed food records. RHR was obtained from 3 consecutive R-wave intervals on 12-lead electrocardiography. Cox models were used to estimate the multivariable hazard ratios (HRs) and 95% confidence intervals (95% CIs) adjusting for possible confounders. Results: During the follow-up period, 617 cardiovascular deaths were observed. The median daily intake of LCn3FAs was 0.37% kcal (0.86. g/day). The interaction between dietary LCn3FAs intake and RHR in the risk of cardiovascular mortality was statistically significant (p= 0.033). The risk of cardiovascular mortality was significantly higher in the low-intake group (<0.37%. kcal) with an RHR >85. beats/min (bpm) [hazard ratio (HR), 1.67; 95% confidence interval (CI), 1.15-2.43], but not in the high-intake group (≥0.37%. kcal) with an RHR >85. bpm (HR, 0.92; 95% CI, 0.61-1.38), compared with those in the high-intake group with an RHR <70. bpm. Similar results were observed with stroke mortality, but not with cardiac mortality. Conclusions: The risk of cardiovascular mortality associated with increased RHR is elevated in participants with low dietary LCn3FAs intake, but not in participants with high dietary LCn3FAs intake in a representative Japanese general population. These results suggest that high dietary LCn3FAs intake may prevent cardiovascular mortality associated with increased RHR.
AB - Background: Increased resting heart rate (RHR) independently predicts cardiovascular mortality. Meanwhile, long-chain n-3 fatty acids (LCn3FAs) have a cardioprotective effect. Our aim was to evaluate whether higher LCn3FAs intake attenuates the elevated risk of cardiovascular mortality associated with increased RHR. Methods: We conducted a population-based 24-year prospective cohort study of Japanese, whose LCn3FAs intake is relatively high. Study participants included 8807 individuals aged 30-95 years from randomly selected areas across Japan without cardiovascular diseases and anti-hypertensive drugs at baseline. The primary endpoint was cardiovascular mortality, and the secondary endpoints were cardiac and stroke mortality during 24 years of follow-up. Individual dietary LCn3FAs intake was estimated from household-based 3-day weighed food records. RHR was obtained from 3 consecutive R-wave intervals on 12-lead electrocardiography. Cox models were used to estimate the multivariable hazard ratios (HRs) and 95% confidence intervals (95% CIs) adjusting for possible confounders. Results: During the follow-up period, 617 cardiovascular deaths were observed. The median daily intake of LCn3FAs was 0.37% kcal (0.86. g/day). The interaction between dietary LCn3FAs intake and RHR in the risk of cardiovascular mortality was statistically significant (p= 0.033). The risk of cardiovascular mortality was significantly higher in the low-intake group (<0.37%. kcal) with an RHR >85. beats/min (bpm) [hazard ratio (HR), 1.67; 95% confidence interval (CI), 1.15-2.43], but not in the high-intake group (≥0.37%. kcal) with an RHR >85. bpm (HR, 0.92; 95% CI, 0.61-1.38), compared with those in the high-intake group with an RHR <70. bpm. Similar results were observed with stroke mortality, but not with cardiac mortality. Conclusions: The risk of cardiovascular mortality associated with increased RHR is elevated in participants with low dietary LCn3FAs intake, but not in participants with high dietary LCn3FAs intake in a representative Japanese general population. These results suggest that high dietary LCn3FAs intake may prevent cardiovascular mortality associated with increased RHR.
KW - Cardiovascular disease
KW - Electrocardiography
KW - Fatty acids
KW - Heart rate
KW - Prevention
UR - http://www.scopus.com/inward/record.url?scp=84926249190&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84926249190&partnerID=8YFLogxK
U2 - 10.1016/j.jjcc.2014.01.005
DO - 10.1016/j.jjcc.2014.01.005
M3 - Article
C2 - 24529505
AN - SCOPUS:84926249190
SN - 0914-5087
VL - 64
SP - 218
EP - 224
JO - Journal of Cardiography
JF - Journal of Cardiography
IS - 3
ER -